Screening for Hidden Prescribing Cascades in Complex Care

Abstract

Prescribing cascades, in which the side effect of a drug is misinterpreted as a new medical condition leading to the prescription of additional medications, present a significant challenge in patients with complex care needs. This review systematically examines the prevalence, mechanisms, risk factors, clinical identification, diagnostic approaches, and management of hidden prescribing cascades. Emphasis is placed on recent research, clinical guidelines, and strategies to promote safe and effective medication use in complex patient populations.

Introduction

Polypharmacy is increasingly prevalent in modern medical practice, particularly among older adults and those with multimorbidity. Hidden prescribing cascades, where adverse drug reactions are inadvertently treated as new illnesses, contribute to medication burden, increased morbidity, and healthcare costs. Recognizing and screening for these cascades is critical to optimize pharmacotherapy, improve patient safety, and reduce avoidable harm in complex care settings.

Epidemiology / Disease Burden

Prescribing cascades are common, with studies estimating prevalence rates ranging from 4% to 35% in older adults, depending on population and methodology. The risk is heightened in long-term care, geriatrics, and patients with multiple chronic conditions. Cascades contribute to adverse drug events, hospitalizations, and functional decline. For example, the use of calcium channel blockers can cause ankle edema, which is then misattributed to a new diagnosis and treated with diuretics, compounding the risk of electrolyte disturbances and falls. The true burden is likely underestimated due to underrecognition and documentation challenges.

Pathophysiology

Prescribing cascades arise when the pharmacologic effects or adverse reactions of medications are misclassified as new disease entities. This misclassification is often facilitated by overlapping symptomatology, diagnostic overshadowing, and insufficient medication review. Drug-induced adverse effects may be subtle or atypical, particularly in frail or elderly patients with altered pharmacodynamics and pharmacokinetics. Examples include anticholinergic toxicity presenting as cognitive decline or antihypertensives causing orthostatic hypotension.

Risk Factors

Key risk factors for hidden prescribing cascades include advanced age, polypharmacy, cognitive impairment, multimorbidity, transitions of care, and lack of regular medication reconciliation. Inadequate communication between healthcare providers, incomplete medication histories, and time constraints during consultations also contribute. Vulnerable populations, such as those with limited health literacy or fragmented care, are at particular risk.

Clinical Features

Clinically, prescribing cascades manifest as new or worsening symptoms following the initiation of a medication. These symptoms may mimic disease progression or new-onset pathology. Common presentations include onset of parkinsonism after antipsychotic use, gastrointestinal symptoms with NSAIDs treated by proton pump inhibitors, or urinary incontinence after diuretic initiation. The temporal relationship between medication changes and symptom onset is a critical diagnostic clue.

Diagnosis

Diagnosis of prescribing cascades requires thorough medication reconciliation, detailed history-taking, and high index of suspicion. Clinicians should systematically review the timing of symptom onset in relation to medication initiation, consider drug-induced etiologies, and utilize validated tools such as the Medication Appropriateness Index. Involvement of clinical pharmacists and multidisciplinary teams enhances cascade detection. Diagnostic algorithms and electronic prescribing alerts are emerging tools to assist in identifying potential cascades.

Treatment & Management

Management centers on deprescribing or substituting the offending agent, treating the underlying adverse drug reaction, and providing supportive care. Shared decision-making with patients and caregivers is essential. Non-pharmacologic interventions and regular medication reviews should be incorporated into routine care. Tapering regimens and close monitoring are recommended to mitigate withdrawal effects and recurrence of symptoms.

Recent Advances / Emerging Therapies

Recent advances include the development of electronic health record-based clinical decision support systems to flag potential cascades at the point of prescribing. Artificial intelligence and machine learning algorithms are being validated to predict high-risk medication combinations and patient profiles. Educational initiatives targeting prescribers have shown promise in reducing cascade incidence. Pharmacogenomics may offer future opportunities for more personalized medication management by identifying patients at elevated risk for adverse drug reactions.

Guideline Recommendations

Professional societies and guideline panels, such as the American Geriatrics Society and Choosing Wisely campaign, emphasize the importance of regular medication review, avoidance of unnecessary prescriptions, and heightened vigilance for adverse drug events. Recommendations include implementing systematic screening for cascades in high-risk populations, integrating pharmacist-led medication reconciliation, and using explicit deprescribing protocols. Guidelines advocate for patient and caregiver education regarding potential drug side effects and cascade risk.

Conclusion

Screening for hidden prescribing cascades is a critical component of safe medication management in complex care. Enhanced recognition, multidisciplinary collaboration, and adherence to evidence-based guidelines can minimize cascade risk, reduce polypharmacy, and improve clinical outcomes. Continued research and innovation in diagnostic support tools, prescriber education, and patient engagement are essential to addressing this pervasive challenge in modern healthcare.